TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2008

Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT).

John E Levine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.